Related references
Note: Only part of the references are listed.Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne's model of dormancy
Sajith Raghunandanan et al.
JOURNAL OF ANTIBIOTICS (2018)
Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA
Yi Xia et al.
LIFE SCIENCE ALLIANCE (2018)
Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9
Alvaro A. Ordonez et al.
DISEASE MODELS & MECHANISMS (2016)
Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice
Scott M. Irwin et al.
ACS INFECTIOUS DISEASES (2016)
Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis
Scott M. Irwin et al.
DISEASE MODELS & MECHANISMS (2015)
Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis
Jean-Philippe Lanoix et al.
DISEASE MODELS & MECHANISMS (2015)
The association between sterilizing activity and drug distribution into tuberculosis lesions
Brendan Prideaux et al.
NATURE MEDICINE (2015)
Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis: A Systematic Review
Marva Seifert et al.
PLOS ONE (2015)
Characterization of a Novel Necrotic Granuloma Model of Latent Tuberculosis Infection and Reactivation in Mice
Noton K. Dutta et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis
Juliane Ollinger et al.
PLOS ONE (2013)
Evaluation of a Mouse Model of Necrotic Granuloma Formation Using C3HeB/FeJ Mice for Testing of Drugs against Mycobacterium tuberculosis
Emily R. Driver et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions
Jamie Harper et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Dominant Role of the sst1 Locus in Pathogenesis of Necrotizing Lung Granulomas during Chronic Tuberculosis Infection and Reactivation in Genetically Resistant Hosts
Alexander V. Pichugin et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Biphasic Kill Curve of Isoniazid Reveals the Presence of Drug-Tolerant, Not Drug-Resistant, Mycobacterium tuberculosis in the Guinea Pig
Zahoor Ahmad et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Isoniazid bactericidal activity and resistance emergence: Integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations
Tawanda Gumbo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid
Catherine Vilcheze et al.
NATURE MEDICINE (2006)
Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant
XB Zhao et al.
BIOCHEMISTRY (2006)
Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models
AJ Lenaerts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Isoniazid pharmacokinetics-pharmaco dynamics in an aerosol infection model of tuberculosis
R Jayaram et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Share Paper
